Abbott reported $106M in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
Abbott USD 106M 28M Mar/2026
Agilent USD 15M 2M Dec/2025
AtriCure USD 1.24M 86K Mar/2026
Baxter International USD 12M 1000K Mar/2026
Becton, Dickinson and Co. USD 9M 5M Mar/2026
Bio-Rad Laboratories USD 21M 10M Mar/2026
Boston Scientific USD 4M 3M Dec/2022
Danaher USD 1.23 27M Jun/2026
Dexcom USD 19.5M 4M Mar/2026
Edwards Lifesciences USD 56.3M 17.7M Dec/2025
Globus Medical USD 815K 3.08M Dec/2024
Insulet USD 4.9M 800K Mar/2026
Integra LifeSciences USD 4.11M 256K Mar/2026
Intuitive Surgical USD 85.1M 6.2M Mar/2026
J&J USD 2.27 0.13 Jun/2026
Medtronic USD 114M 23M Jan/2025
Merit Medical Systems USD 3.9M 4K Mar/2026
Pfizer USD -0.04 115M Jun/2026
Smith & Nephew USD 15M 6M Dec/2024
Stryker USD 38M 9M Mar/2025
Tandem Diabetes Care USD 3.63M 610K Mar/2026
Teleflex USD 1.71M 1.03M Mar/2026
Terumo JPY 1.04B 121M Mar/2024
Thermo Fisher Scientific USD 233M 25M Mar/2026